On-demand, in-home care company Sprinter Health secured $55 million in a Series B financing round led by General Catalyst.
Andreessen Horowitz (a16z) Bio + Health and other existing investors, including the Regents of the University of California, Google Ventures and Accel, participated in the round.
WHAT IT DOES
Sprinter Health partners with regional healthcare organizations and sends nurses and phlebotomists to patients' homes to conduct blood draws, vitals checks and medical tests, including COVID-19.
Patients can book appointments via an app and receive notifications when the provider is en route.
The company will use the funds to scale its technologies and expand its services.
"We’ve been relatively quiet publicly for the past few years because we wanted to demonstrate we could affordably get to patients’ homes, give them a great clinical experience and drive ROI for our payer partners," Max Cohen, cofounder and CEO of Sprinter Health, told MobiHealthNews.
"Now that we’ve done that, it’s about replicating the model to have a true national presence to bring the Sprinter version of home care to millions of patients a year."
MARKET SNAPSHOT
In 2022, Sprinter Healthcare partnered with Firefly Health to integrate its home clinical services into Firefly's virtual primary care.
Firefly members can receive lab draws, vital checks, electrocardiograms, diabetic eye exams and food screenings at home via Sprinter's phlebotomists and nurses. Firefly physicians receive the lab results and notes electronically for review.
In 2021, Sprinter Health raised $33 million in Series A funding.
The round was led by Andreessen Horowitz, with participation from investors including General Catalyst, Accel and Google Ventures. Angel investors included DoorDash cofounder and CEO Tony Xu and former U.S. Sen. Bill Frist of Tennessee.
Other companies in the home care space include Reimagine Care, which joined forces with MedStar Health in April to integrate its on-demand oncology care platform into the health system's cancer care delivery model and assist patients with the transition from in-clinic care to the home.
Reimagine Care's patient-centered model provides patients with customized, all-inclusive care from their homes, utilizing technology, data insights and a multidisciplinary care team.
The partnership with Reimagine Care allows MedStar Health to extend its cancer care services beyond the clinic, including additional symptom management, remote patient monitoring and supportive care.
In 2024, Melbourne-based Kismet received $8.2 million in seed funding from a round led by tech investors Prosus Ventures and Airtree Ventures.
Kismet's engagement ecosystem digitally links care receivers, caregivers, health insurance and healthcare providers in the in-home, disabled and aged segments worldwide.
The company's web and mobile-based platform, Kismet Participant, organizes healthcare providers, classified by distance, rating or price, into more than 30 categories that can match an individual's insurance benefits or NDIS (National Disability Insurance Scheme) plan.
In 2023, Best Buy Health and Mass General Brigham announced the tech giant would provide technology, human-centered aid and omnichannel logistics to scale and support the health system's acute home-based care offering, Home Hospital, and Medicare-certified home health business, Home Care.
Home Hospital provides home healthcare for patients with conditions such as infections, chronic obstructive pulmonary disease and heart disease who would otherwise need hospitalization.
The care team comprises advanced practice providers, paramedics, nurses, physicians and other clinicians.
English (US) · 